封面
市场调查报告书
商品编码
1920926

2025-2029年癌症治疗技术领域的成长机会

Growth Opportunities in Cancer Treatment Technologies, 2025-2029

出版日期: | 出版商: Frost & Sullivan | 英文 57 Pages | 商品交期: 最快1-2个工作天内

价格
简介目录

放射线治疗和非放射线治疗推动癌症治疗的变革性发展

癌症治疗技术在透过放射线治疗和非放射线治疗有效清除癌性肿瘤方面发挥着至关重要的作用。这些治疗方法提供高度局部、微创/非侵入性和个人化的治疗方案,有助于有效清除肿瘤。

全球癌症病例日益增多(主要原因是人们对癌症的认识不断提高,以及能够更早诊断的解决方案的出现),这正在加速这些技术的大规模应用。

医疗机构选择这些治疗方法是因为它们能够在有效切除肿瘤的同时保护健康组织,从而改善患者的治疗效果。

Frost & Sullivan的这项研究将癌症治疗技术分为「放射线治疗」和「非放射线治疗」。放射线治疗透过电离能破坏癌细胞的DNA来发挥作用,而非放射线治疗则无需电离辐射即可杀死癌细胞。放射线治疗包括生物导引放射线治疗、近距离放射、自适应放射线治疗、电子近距离放射疗法和表浅放射线治疗。非放射线治疗包括组织溶解疗法(聚焦超音波)、微波消融、水磨术、水热蒸气疗法和用于肿瘤治疗的电磁场疗法。

目录

战略要务

  • 为什么经济成长变得越来越困难?
  • 策略要务八要素™:影响成长的因素
  • The Strategic Imperative 8(TM)
  • 三大策略要务对癌症治疗产业的影响
  • 成长机会驱动Growth Pipeline Engine(TM)™
  • 调查方法

成长机会分析

  • 分析范围
  • 按技术细分

成长泉

  • 成长要素
  • 成长限制因素

细分市场分析—放射肿瘤学

  • 放射治疗概述
  • 放射肿瘤学主要企业- 主要创新
  • 其他放射治疗创新者

细分市场分析—非放射线治疗

  • 非放射线治疗概述
  • 非放射线治疗的主要企业- 主要创新
  • 其他非放射线治疗创新者

资金筹措分析

  • 公共资金用于放射治疗和非放射治疗技术
  • 放射治疗和非放射治疗技术的私人资金
  • 放射治疗和非放射治疗技术的公共和私人资金

市场分析

  • 伙伴关係分析

专利状态

  • 癌症治疗技术专利分析
  • 主要专利

癌症治疗技术领域的成长机会。

  • 成长机会 1:在癌症治疗过程中应用人工智慧
  • 成长机会 2:多方向高能量敏捷扫描电子放射治疗
  • 成长机会3:透过与契约製造组织合作外包医疗设备

附录

  • 技术成熟度等级(TRL)解释

未来发展

  • 成长机会带来的益处和影响
  • 下一步
  • 免责声明
简介目录
Product Code: DB31

Radiation and Non-radiation Therapies to Drive Transformational Growth in Cancer Management

Cancer treatment technologies are playing an instrumental role in the effective removal of cancerous tumors through radiation and non-radiation therapies. These therapies offer highly localized, minimally invasive/non-invasive, and personalized treatment options that support effective tumor removal.

The growing burden of cancer cases globally-primarily driven by increased awareness about the condition and the availability of solutions enabling early diagnosis-is accelerating large-scale adoption of these technologies.

Healthcare providers are opting for these therapies because they facilitate effective tumor removal while sparing healthy tissues, thereby improving patient outcomes.

This Frost & Sullivan research study categorizes cancer treatment technologies into radiation therapies, which work by delivering ionizing energy to damage the DNA of cancer cells, and non-radiation therapies, which kill cancer cells without ionizing radiation. Radiation therapy includes biology-guided radiotherapy, brachytherapy, adaptive radiation therapy, electronic brachytherapy, and superficial radiation therapy. Non-radiation therapy includes histotripsy (focused ultrasound), microwave ablation, aquablation, thermal water vapor therapy, and tumor treating fields.

Table of Contents

Strategic Imperatives

  • Why Is It Increasingly Difficult to Grow?
  • The Strategic Imperative 8™: Factors Creating Pressure on Growth
  • The Strategic Imperative 8™
  • The Impact of the Top 3 Strategic Imperatives on the Cancer Treatment Technologies Industry
  • Growth Opportunities Fuel the Growth Pipeline Engine™
  • Research Methodology

Growth Opportunity Analysis

  • Scope of Analysis
  • Segmentation by Technologies

Growth Generator

  • Growth Drivers
  • Growth Restraints

Segment Analysis-Radiation Therapy

  • Radiation Therapy-Overview
  • Radiation Therapy Players-Key Innovations
  • Other Radiation Therapy Innovators

Segment Analysis-Non-radiation Therapy

  • Non-radiation Therapy-Overview
  • Non-radiation Therapy Players-Key Innovations
  • Other Non-radiation Therapy Innovators

Funding Analysis

  • Public Funding for Radiology and Non-radiology Therapy Technologies
  • Private Funding for Radiology and Non-radiology Therapy Technologies
  • Public and Private Funding for Radiology and Non-radiology Therapy Technologies

Market Analysis

  • Partnership Analysis

Patent Landscape

  • Patent Analysis for Cancer Treatment Technologies
  • Key Patents

Growth Opportunity Universe in Cancer Treatment Technologies

  • Growth Opportunity 1: Use of AI Across the Entire Cancer Care Continuum
  • Growth Opportunity 2: Pluridirectional High-Energy Agile Scanning Electronic Radiotherapy
  • Growth Opportunity 3: Medical Device Outsourcing Through Partnership with Contract Manufacturing Organizations

Appendix

  • Technology Readiness Levels (TRL): Explanation

Next Steps

  • Benefits and Impacts of Growth Opportunities
  • Next Steps
  • Legal Disclaimer